Worldwide demand for neurorehabilitation devices is expected to rise at a prolific CAGR of 15% from 2022 to 2026. At present, the global neurorehabilitation devices market is valued at US$ 1.3 billion and is anticipated to reach a market valuation of US$ 2.3 billion by 2026.
Demand for neurorobotic systems is expected to balloon at 16% CAGR over the forecast period. People who are physically weak or have experienced trauma receive body assistance from neurorobotic systems. The high availability and increasing efforts by producers to create innovative systems and platforms are major factors driving the sales of neurorobotic systems.
Download Sample Copy of This Report: –https://www.factmr.com/connectus/sample?flag=S&rep_id=7600?PJ
Market Players: –
- Neofect
- AlterG, Inc.
- Eodyne
- Kinestica
- Hocoma AG
- Abbott Laboratories
- Medtronic plc
- Biometrics Ltd.
- Bioness Inc.
- BIONIK Laboratories Corp.
- Boston Scientific Corporation
- Ekso Bionics Holdings Inc.
The examiners have utilized various vast conspicuous business knowledge devices to unite realities, figures, and market information into income assessments and projections in the Market.
Key partners in Market including industry players, policymakers, and financial backers in different nations have been persistently realigning their systems and ways to deal with carry out them to take advantage of new open doors. Numerous lately have updated their procedures to stay coordinated in the setting of overall disturbances brought about by the COVID-19 pandemic.
Key Segments in Neurorehabilitation Devices Industry Research
- By Product :
- Neurorobotic Systems
- Brain Computer Interface
- Wearable Devices
- Brain Stimulators
- By Application :
- Stroke
- Parkinson’s Disease
- Brain & Spinal Cord Injury
- Cerebral Palsy
- Multiple Sclerosis
- Others
- By End User :
- Rehabilitation Centers
- Hospitals & Clinics
- Home Care
- Others
- By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Competitive Landscape
Key players in the global neurorehabilitation devices market are focused on obtaining regulatory clearances, developing technologically advanced products, introducing new products, and partnering with and acquiring other businesses.
For instance :
- In 2022, to enhance the creation of technologically advanced brain-computer interface solutions, Blackrock Neurotech acquired MindX. By combining its hardware DNA with MindX’s software DNA, Blackrock aimed to improve its neural data analysis and offer flexibility and modification for numerous BCI applications.
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
- EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
- CIS & Russia
- Japan
- Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
How Fact.MR Assists in Making Strategic Moves?
The data provided in the Neurorehabilitation Devices Market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.
Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=RC&rep_id=7600?PJ